PL EN


Preferences help
enabled [disable] Abstract
Number of results
2000 | 48 | 4 | 225-233
Article title

Differential effects of CD40 stimulation on normal and neoplastic cell growth

Title variants
Languages of publication
EN
Abstracts
EN
CD40 is a molecule in the tumor necrosis factor receptor/nerve growth factor receptor (TNFR/NGFR) family that is present on both normal and neoplastic B lineage cells. It is also expressed on carcinoma and melanoma cells and can be augmented with interferon gamma CD40 stimulation in normal Bcells has been demonstrated to promote normal B cell differentiation and growth in vitro. In contrast to these effects, CD40 stimulation by either anti-CD40 antibodies or a recombinant soluble CD40 ligand can inhibit the growth of human breast carcinomas and aggressive histology B lymphomas in vitro and in vivo. This is believed to occur by activation- -induced cell death (AICD) in which stimuli that promote the growth of normal cell types inhibit the growth of neoplastic counterparts. This occurs through the induction of apoptosis, necrosis and/or cell cycle arrest. Thus, CD40 stimulation may be of potential clinical use in the treatment of carcinomas and B cell lymphomas. This review shall provide an overview of the various effects of CD40 stimulation on both normal and neoplastic cell types.
Keywords
Publisher

Year
Volume
48
Issue
4
Pages
225-233
Physical description
Contributors
author
author
author
author
References
Document Type
REVIEW
Publication order reference
J.L. Ziebold, NCI-FCRDC, Laboratory of Leukocyte Biology, Frederick, Maryland, USA
Identifiers
YADDA identifier
bwmeta1.element.element-from-psjc-46a4b906-9381-3cc4-8568-2bf08132a819
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.